Inventor
Hu taishan
CN25 patents
⚠️ This page may combine multiple inventors who share the name “Hu taishan”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOFFMANN LA ROCHE
18 patentsUS9447086B2Sep 20, 2016
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE34 citations93
US9233978B2Jan 12, 2016
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE18 citations91
US10428069B2Oct 1, 2019
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE6 citations83
US10081627B2Sep 25, 2018
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE9 citations83
US9890167B2Feb 13, 2018
Pyrazine compounds for the treatment of infectious diseases
HOFFMANN LA ROCHE4 citations72
US11098080B2Aug 24, 2021
Peptide macrocycles against Acinetobacter baumannii
HOFFMANN LA ROCHE3 citations71
US10030047B2Jul 24, 2018
Peptide macrocycles against acinetobacter baumannii
HOFFMANN LA ROCHE2 citations71
US9758530B2Sep 12, 2017
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE3 citations71
US9266904B2Feb 23, 2016
6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE5 citations71
US11505573B2Nov 22, 2022
Peptide macrocycles against Acinetobacter baumannii
HOFFMANN LA ROCHE2 citations70
US12351575B2Jul 8, 2025
6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
HOFFMANN LA ROCHE0 citations61
US11168086B2Nov 9, 2021
Methods of synthesizing pyrazine compounds
HOFFMANN LA ROCHE0 citations61
US10562905B2Feb 18, 2020
Carboxy tetrahydropyrazolopyrazine compounds for the treatment of infectious diseases
HOFFMANN LA ROCHE1 citations61
US12012466B2Jun 18, 2024
Peptide macrocycles against Acinetobacter baumannii
HOFFMANN LA ROCHE0 citations60
US12252484B2Mar 18, 2025
Pyrazolopyridine compounds for the treatment of autoimmune disease
HOFFMANN LA ROCHE0 citations52
US10781206B2Sep 22, 2020
Tetrahydropyrazolopyridine compounds for the treatment of infectious diseases
HOFFMANN LA ROCHE0 citations41
US10683299B2Jun 16, 2020
Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseases
HOFFMANN LA ROCHE0 citations41
US10604527B2Mar 31, 2020
Pyrazine compounds for the treatment of hepatitis B infection
HOFFMANN LA ROCHE0 citations40
ZHEJIANG HISUN PHARM CO LTD
6 patentsUS11384097B2Jul 12, 2022
Tetrahydroisoquinoline derivative, preparation method therefor and use thereof
ZHEJIANG HISUN PHARM CO LTD2 citations54
US12447151B2Oct 21, 2025
Alkyne derivative, preparation method for same, and uses thereof
ZHEJIANG HISUN PHARM CO LTD0 citations48
US12559449B2Feb 24, 2026
Aromatic ring or heteroaromatic ring derivatives, preparation method therefor and use thereof
ZHEJIANG HISUN PHARM CO LTD0 citations45
US12410191B2Sep 9, 2025
Macrolide derivatives, preparation method and application thereof
ZHEJIANG HISUN PHARM CO LTD0 citations45
US11897863B2Feb 13, 2024
Indazole amine derivative, preparation method therefor and medical use thereof
ZHEJIANG HISUN PHARM CO LTD0 citations44
US12234222B2Feb 25, 2025
Piperazine amide derivative, preparation method therefor, and use thereof in medicine
ZHEJIANG HISUN PHARM CO LTD0 citations43